Boehringer Ingelheim and Lilly Alliance
The conference has been instigated and organised by ABCD. Sponsors* have contributed funding towards this event in return for exhibition space. They have had no input into the agenda or the selection of speakers with the exception of any sponsored symposia which are clearly indicated.
*A. Menarini Farmaceutica Internazionale ERL, Boehringer-Ingelheim and Lilly Alliance, Daiichi Sankyo UK, Medice UK Ltd, Novo Nordisk
Boehringer Ingelheim and Eli Lilly and Company
The Boehringer Ingelheim and Lilly Alliance leverages the strengths of two of the world's leading pharmaceutical companies. By joining forces, the companies demonstrate their commitment, not only to the care of people with type 2 diabetes, but also to address areas of medical need like heart failure and chronic kidney disease.
